Loading...

CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC Company Mergers 8-K Filing

CHRL

CRL

CHARLES RIVER LABORATORIES INTERNATIONAL INC

(CRL)

2026 8-K

Planned Divestitures

Management Change

Financial Results Released

Conference Presentation

Leadership Transition

Investor Conference Update

SEC Investigation Concluded

Financial Results

Management Change

Management Change

Financial Statements

Financial Statements

Share Purchases

Financial Results

Healthcare Conference

Credit Agreement Update

Q3 Financial Results

Earnings Reports

Shareholder Meeting

Earnings Reports

Earnings Reports

Appointment of Director

Management Change

Purchase of Shares

Financial Results for Q3 2023

Financial Results for Q2 2023

Annual Meeting of Shareholders

Earnings Report

Earnings Reports

External Links:

Charles River Laboratories announced plans for a presentation at the J.P. Morgan Healthcare Conference on January 13, 2026, discussing improving demand trends and upcoming acquisitions of K.F. (Cambodia) Ltd. for $510 million and PathoQuest SAS for approximately $60 million, expected to enhance revenue projections.

AI Assistant

CHARLES RIVER LABORATORIES INTERNATIONAL INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.